Background Cancer is characterized by the rampant proliferation, growth, and infiltration of
malignantly transformed cancer cells past their normal boundaries into adjacent tissues. It is …

Currently, Nuclear Medicine has a clearly defined role in clinical practice due to its
usefulness in many medical disciplines. It provides relevant diagnostic and therapeutic …

This article is an update of the requirements of a specialist breast centre, produced by
EUSOMA and endorsed by ECCO as part of Essential Requirements for Quality Cancer …

Summary Response Assessment in Neuro-Oncology (RANO) response criteria have been
established and were updated in 2023 for MRI-based response evaluation of diffuse …

Background ECCO essential requirements for quality cancer care (ERQCC) are checklists
and explanations of organisation and actions that are necessary to give high-quality care to …

Personalized medicine represents a major goal in oncology. It has its underpinning in the
identification of biomarkers with diagnostic, prognostic, or predictive values. Nowadays, the …

Molecular imaging, such as positron emission tomography (PET), is increasingly used as
biomarker to predict and assess treatment response in breast cancer. The number of …

Bone is a common metastasis site in several malignancies, most importantly prostate and
breast cancers. Given the significance of the early and accurate diagnosis of bone …

Objective To report 15 years of experience with metabolic tumor volume (MTV) of liver
metastases from the preoperative 18F-FDG PET/CT to predict long-term survival after liver …

Abstract European Cancer Organisation Essential Requirements for Quality Cancer Care
(ERQCC) are written by experts representing all disciplines involved in cancer care in …